Clinical Trials Directory

Trials / Completed

CompletedNCT02978131

Histopathological Techniques and PCR on Tissues Included in Paraffin for the Diagnosis of Tuberculosis

Evaluation of the Sensitivity of Histopathological Techniques and Molecular Biology (PCR) on Tissues Fixed in Paraformaldehyde and Included in Paraffin for the Diagnosis of Tuberculosis in Current Practice

Status
Completed
Phase
Study type
Observational
Enrollment
20 (actual)
Sponsor
Lille Catholic University · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Tuberculosis (TB) remains a major public health problem nowadays. About 30% of the world population is infected with Mycobacterium tuberculosis. There is an increase in the number of cases of classic tuberculosis in developing countries, even if number of cases are declining in developed countries. However, in developed countries this decrease is counterbalanced by the emergence of multidrug resistant (MDR) strains of the bacteria. There are also latent forms (1/3 of the world population) of the infection that can be reactivated in one case out of ten. Each year, about 2 million people die of tuberculosis and 9 million new cases are identified, including about 500,000 cases of MDR TB. The spread of this disease as well as the increasing number of cases of MDR tuberculosis, reinforce the need for research and development of strategies of diagnosis and management of this affection. Nowadays, the culture is the gold standard for the TB diagnosis but this technique needs at least three weeks to be performed. The objective of this study is to evaluate the sensitivity and specificity of histopathological and molecular techniques (PCR) on paraformaldehyde fixed and embedded in paraffin tissues for a faster diagnosis of tuberculosis in current practice, in order to administrate an efficient treatment as soon as possible.

Conditions

Interventions

TypeNameDescription
OTHERHistopathological study
OTHERMolecular study (Polymerase chain reaction)

Timeline

Start date
2015-05-01
Primary completion
2016-06-01
Completion
2017-06-01
First posted
2016-11-30
Last updated
2019-03-20

Source: ClinicalTrials.gov record NCT02978131. Inclusion in this directory is not an endorsement.